Home
Seres Therapeutics

Seres Therapeutics Market Share Analysis for June 2026

Learn about the information we collect, how we use it, and the choices you have about our use of your information.

Health > Biotechnology and Pharmaceuticals

Domainserestherapeutics.com

Year Founded2010

Employees51 - 200

Annual Revenue$100M - $200M

Seres Therapeutics

Seres Therapeutics (including company regionals)

serestherapeutics.com

See more website traffic and engagement information

Seres Therapeutics Revenue up to June 2026 is 100M - 200M

revenue generated by Seres Therapeutics top domains

Seres Therapeutics top domains revenue over 3 years

Revenue for Seres Therapeutics top domains

serestherapeutics.com100M - 200M

See more with Sales Intelligence

Total visits to Seres Therapeutics's top domains

Understand Seres Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

serestherapeutics.com4.7K

See more with Sales Intelligence

Avg. visit duration in Seres Therapeutics's top domains

Analyze Seres Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

serestherapeutics.com00:00:31

See more with Sales Intelligence

Avg. pageviews on Seres Therapeutics's top domains

See how Seres Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

serestherapeutics.com1.99

See more with Sales Intelligence

Seres Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Seres Therapeutics

These are the website technologies, by industry, used by Seres Therapeutics top domains

Content Management System (6)

WordPress

Widget (5)

Twemoji

Conversion & Analytics (3)

Google Analytics

Email Services (2)

G Suite

More Technologies

8

See all

News & Signals from Seres Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSeres Health sold assets to Nestlé Health Science in the amount of $155M on Jul 1st '24.The agreement follows Seres' 2024 sale of the VOWST business to Nestlé Health Science.

NewsSeres Health attended event H.C. Wainwright Global Investment Conference on May 19th '26.Seres Therapeutics to participate in H.C. Wainwright 4th Annual BioConnect Investor Conference.

NewsSeres Health has earnings of $32.7M.Seres Therapeutics, Inc. reported a net loss of $19.9 million for the three months ended March 31, 2026, compared with net income of $32.7 million a year earlier, as revenue totaled only $0.4 million from a government grant.